Recent Updates
Recently added Catalysts
IMRN Positive Sentiment Score: 70/100

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Tuesday, November 28, 2023 1 min read
Key Takeaway: Immuron Limited is hosting an investor webinar on November 30, 2023, led by CEO Steven Lydeamore, who will discuss the company's current status and future milestones. Participants will have the chance to engage directly with Mr. Lydeamore during a question-and-answer session. This event emphasizes Immuron's dedication to transparency and investor relations as they work on developing targeted polyclonal antibodies for infectious diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • The investor webinar presents an opportunity for direct engagement with the CEO.
  • Upcoming milestones are anticipated, indicating business growth.
  • Immuron's focus on innovative treatments could attract investor interest.

Full Press Release Details

MELBOURNE, Australia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to invite shareholders to attend an investor webinar “Coffee Microcaps Morning Meeting”, to be held on Thursday, 30th of November, 2023, 9:00am ADEST.
CEO Steven Lydeamore will provide an overview and update on the business and upcoming milestones.
Following the presentation, attendees will have the opportunity to ask questions directly to Mr Lydeamore during a moderated Q & A session.
This webinar can be viewed live via zoom & you register via the link below.
Zoom: https://us02web.zoom.us/webinar/register/WN_73dRq8CsQK6Ahor0F8UzgA#/registration
Authorised for release by the Board of Immuron Limited.
Immuron Limited (ASX: IMC, NASDAQ: IMRN) is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.
For more information visit: http://www.immuron.com

Tags

Frequently Asked Questions

What is the date and time of the Immuron investor webinar?

The investor webinar is on November 30, 2023, at 9:00 am ADEST.

Who will present at the Coffee Microcaps Morning Meeting?

CEO Steven Lydeamore will present an overview and business update.

Can attendees ask questions during the webinar?

Yes, there will be a moderated Q&A session for attendees to ask questions.

How can I register for the Immuron webinar?

You can register for the webinar via the provided Zoom registration link.

What is Immuron Limited's main focus?

Immuron Limited focuses on developing and commercializing targeted polyclonal antibodies.

Tags: IMRN Viatris Investor Conferences Healthcare Immuron Steven Lydeamore investor webinar biopharmaceuticals polyclonal antibodies
Last updated: Nov 28, 2023